ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,567.30
-0.98%
S&P ASX All Technology
2,930.40
-1.06%
Brent Oil
86.625
0.24%
US Dollar vs AUD
1.5586
0.13%
Bitcoin
64,382.61
1.37%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) News

AGRX Agile Therapeutics Inc

0.6022
0.00 (0.00%)
After Hours
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Agile Therapeutics Inc AGRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 0.6022 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.6022 0.6022
more quote information »

Recent News

Date Time Source Heading
28/3/202423:05GLOBEAgile Therapeutics Reports Fourth Quarter & Full Year 2023..
26/3/202407:30GLOBEAgile Therapeutics Announces Delisting from Nasdaq
21/3/202421:35GLOBECorrection - Agile Therapeutics to Report Fourth Quarter and..
20/3/202423:15GLOBEAgile Therapeutics to Report Fourth Quarter and Full Year..
13/3/202422:31GLOBEAgile Therapeutics Completes Pay-off of Debt and Remains..
24/2/202408:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/2/202408:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/2/202401:01GLOBEAgile Therapeutics Announces Exercise of Warrants for $4.8..
16/2/202408:45EDGAR2Form 8-K - Current report
16/2/202408:30GLOBEAgile Therapeutics Announces Extension Granted by Nasdaq..
14/2/202412:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202408:51EDGAR2Form S-1/A - General form for registration of securities..
07/2/202402:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202401:21EDGAR2Form S-1/A - General form for registration of securities..
03/2/202408:27EDGAR2Form S-1/A - General form for registration of securities..
24/1/202401:29GLOBEThe Biden-Harris Administration Announces New Guidance to..
21/12/202300:00EDGAR2Form S-1/A - General form for registration of securities..
13/12/202300:01GLOBEAgile Therapeutics Provides Update on Actions Being Taken to..
12/12/202309:30EDGAR2Form S-1 - General form for registration of securities under..
07/12/202300:00EDGAR2Form 8-K - Current report
05/12/202300:00EDGAR2Form 8-K - Current report
10/11/202308:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202300:15EDGAR2Form 8-K - Current report
10/11/202300:05GLOBEAgile Therapeutics Reports Third Quarter 2023 Financial..
26/10/202323:05GLOBEAgile Therapeutics to Report Third Quarter 2023 Financial..
05/10/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202307:30GLOBEAgile Therapeutics Reports an Inducement Grant to New Chief..
03/10/202307:30EDGAR2Form 8-K - Current report
29/9/202306:50EDGAR2Form 8-K - Current report
05/9/202322:05GLOBEAgile Therapeutics to Present at the H.C. Wainwright 25th..
26/8/202306:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/8/202322:30EDGAR2Form 8-K/A - Current report: [Amend]
10/8/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:10EDGAR2Form 8-K - Current report
09/8/202322:05GLOBEAgile Therapeutics Reports Second Quarter 2023 Financial..
26/7/202322:30GLOBEAgile Therapeutics to Report Second Quarter 2023 Financial..
01/7/202306:50EDGAR2Form 8-K - Current report
01/7/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/7/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/7/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/7/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/7/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/6/202322:01GLOBEAgile Therapeutics Announces the Availability of Twirla® to..
24/6/202302:05GLOBEAgile Therapeutics Commends the Biden Administration’s..
16/6/202306:05GLOBEAgile Therapeutics Announces the Availability of Twirla®..
14/6/202306:05GLOBEAgile Therapeutics Announces New Agreement with vitaCare®..
26/5/202306:05GLOBEAgile Therapeutics Announces Closing of $7.5 Million Public..
23/5/202310:00GLOBEAgile Therapeutics Announces Pricing of $7.5 Million Public..
12/5/202306:05GLOBEAgile Therapeutics Reports First Quarter 2023 Financial..
08/5/202322:00GLOBEAgile Therapeutics to Report First Quarter 2023 Financial..

Your Recent History

NASDAQ
AGRX
Agile Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved